Annual SGA
$180.15 M
+$37.15 M+25.98%
December 31, 2023
Summary
- As of February 20, 2025, CSTL annual SGA is $180.15 million, with the most recent change of +$37.15 million (+25.98%) on December 31, 2023.
- During the last 3 years, CSTL annual SGA has risen by +$132.02 million (+274.29%).
- CSTL annual SGA is now at all-time high.
Performance
CSTL SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly SGA
$50.50 M
-$589.00 K-1.15%
September 30, 2024
Summary
- As of February 20, 2025, CSTL quarterly SGA is $50.50 million, with the most recent change of -$589.00 thousand (-1.15%) on September 30, 2024.
- Over the past year, CSTL quarterly SGA has increased by +$6.41 million (+14.54%).
- CSTL quarterly SGA is now -1.15% below its all-time high of $51.09 million, reached on June 30, 2024.
Performance
CSTL Quarterly SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM SGA
-$860.98 M
+$6.08 M+0.70%
September 30, 2024
Summary
- As of February 20, 2025, CSTL TTM SGA is -$860.98 million, with the most recent change of +$6.08 million (+0.70%) on September 30, 2024.
- Over the past year, CSTL TTM SGA has dropped by -$1.04 billion (-577.92%).
- CSTL TTM SGA is now -1397.64% below its all-time high of -$57.49 million.
Performance
CSTL TTM SGA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Selling, General & Administrative Expenses Formula
SGA = Total Operating Expenses - Cost of Goods Sold - Research & Development
CSTL Selling, General & Administrative Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.0% | +14.5% | -577.9% |
| 3 y3 years | +274.3% | +14.5% | -577.9% |
| 5 y5 years | +993.8% | +14.5% | -577.9% |
CSTL Selling, General & Administrative Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +107.7% | -1.1% | +100.7% | -166.2% | +0.7% |
| 5 y | 5-year | at high | +503.7% | -1.1% | +412.6% | -307.8% | +0.7% |
| alltime | all time | at high | +1080.7% | -1.1% | +1188.8% | -1397.6% | +0.7% |
Castle Biosciences Selling, General & Administrative Expenses History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $50.50 M(-1.2%) | $194.17 M(+3.1%) |
| Jun 2024 | - | $51.09 M(+5.3%) | $188.29 M(+3.5%) |
| Mar 2024 | - | $48.49 M(+10.0%) | $181.88 M(+1.0%) |
| Dec 2023 | $180.15 M(+26.0%) | $44.09 M(-1.2%) | $180.15 M(+3.2%) |
| Sep 2023 | - | $44.62 M(-0.1%) | $174.49 M(+4.8%) |
| Jun 2023 | - | $44.68 M(-4.5%) | $166.50 M(+4.5%) |
| Mar 2023 | - | $46.76 M(+21.7%) | $159.31 M(+11.4%) |
| Dec 2022 | $143.00 M(+64.9%) | $38.43 M(+4.9%) | $143.00 M(+10.2%) |
| Sep 2022 | - | $36.63 M(-2.3%) | $129.74 M(+12.1%) |
| Jun 2022 | - | $37.50 M(+23.1%) | $115.71 M(+16.8%) |
| Mar 2022 | - | $30.45 M(+21.0%) | $99.03 M(+14.2%) |
| Dec 2021 | $86.74 M | $25.16 M(+11.4%) | $86.74 M(+13.3%) |
| Sep 2021 | - | $22.59 M(+8.5%) | $76.54 M(+16.6%) |
| Jun 2021 | - | $20.82 M(+14.7%) | $65.64 M(+18.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | $18.16 M(+21.4%) | $55.22 M(+14.7%) |
| Dec 2020 | $48.13 M(+61.3%) | $14.96 M(+27.8%) | $48.13 M(+11.9%) |
| Sep 2020 | - | $11.70 M(+12.6%) | $43.02 M(+11.9%) |
| Jun 2020 | - | $10.39 M(-6.2%) | $38.44 M(+10.2%) |
| Mar 2020 | - | $11.08 M(+12.4%) | $34.87 M(+16.9%) |
| Dec 2019 | $29.84 M(+81.2%) | $9.85 M(+38.3%) | $29.84 M(+23.5%) |
| Sep 2019 | - | $7.12 M(+4.4%) | $24.16 M(+15.3%) |
| Jun 2019 | - | $6.82 M(+12.8%) | $20.95 M(+14.5%) |
| Mar 2019 | - | $6.05 M(+45.2%) | $18.29 M(+11.0%) |
| Dec 2018 | $16.47 M(+7.9%) | $4.17 M(+6.3%) | $16.47 M(+33.8%) |
| Sep 2018 | - | $3.92 M(-5.8%) | $12.31 M(+46.7%) |
| Jun 2018 | - | $4.16 M(-1.6%) | $8.39 M(+98.4%) |
| Mar 2018 | - | $4.23 M | $4.23 M |
| Dec 2017 | $15.26 M | - | - |
FAQ
- What is Castle Biosciences annual SGA?
- What is the all time high annual SGA for Castle Biosciences?
- What is Castle Biosciences annual SGA year-on-year change?
- What is Castle Biosciences quarterly SGA?
- What is the all time high quarterly SGA for Castle Biosciences?
- What is Castle Biosciences quarterly SGA year-on-year change?
- What is Castle Biosciences TTM SGA?
- What is the all time high TTM SGA for Castle Biosciences?
- What is Castle Biosciences TTM SGA year-on-year change?
What is Castle Biosciences annual SGA?
The current annual SGA of CSTL is $180.15 M
What is the all time high annual SGA for Castle Biosciences?
Castle Biosciences all-time high annual SGA is $180.15 M
What is Castle Biosciences annual SGA year-on-year change?
Over the past year, CSTL annual SGA has changed by +$37.15 M (+25.98%)
What is Castle Biosciences quarterly SGA?
The current quarterly SGA of CSTL is $50.50 M
What is the all time high quarterly SGA for Castle Biosciences?
Castle Biosciences all-time high quarterly SGA is $51.09 M
What is Castle Biosciences quarterly SGA year-on-year change?
Over the past year, CSTL quarterly SGA has changed by +$6.41 M (+14.54%)
What is Castle Biosciences TTM SGA?
The current TTM SGA of CSTL is -$860.98 M
What is the all time high TTM SGA for Castle Biosciences?
Castle Biosciences all-time high TTM SGA is -$57.49 M
What is Castle Biosciences TTM SGA year-on-year change?
Over the past year, CSTL TTM SGA has changed by -$1.04 B (-577.92%)